I also actually hope we see,That the raising was via "unsolicited approach", which the Company thought prudent to make an offer and take advantage of.That's would also be another strong statement.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%